SHIRE PHARMACEUTICALS LIMITED

Company Information

Company Number
02031674
Registered Address
1 Kingdom Street, London, United Kingdom, W2 6BD
Status
Active
Employee Count
0
Turnover
£0
EBITDA
£138,000

Additional Details

Company Type
Private limited Company
Incorporated On
26 June 1986
Nature of Business
21100 - Manufacture of basic pharmaceutical products
46460 - Wholesale of pharmaceutical goods
Industries
Life Sciences And Medical Technology
Region
London

Time to Pay

Average Time to Pay
47 days
Shortest Period:0 days
Longest Period:60 days
Max Contractual:60 days

Payment Timeline

Within 30 Days
55%
31-60 Days
33%
After 60 Days
12%
Not Paid Within Terms9%

Payment Features

Participates in Codes✗ No
E-Invoicing✗ No
Supply Chain Finance✗ No

Performance Reports History

Reporting Period Filed: 2020-10-30
Reporting PeriodFiling DateAverage Time to Pay (days)Paid within 30 daysPaid 31-60 daysPaid after 60 daysNot Paid within Terms
01 Jul 2019 - 31 Dec 201925 Feb 20206252%31%17%21%
01 Jul 2018 - 31 Dec 201828 Jan 20193662%20%17%49%

Payment Time Trends

Payment Distribution Trends

Invoice Payment Practices

This information is as reported by the business, and responses are in their own words.

Payment Terms

Standard payment terms

Terms are applied from invoice receipt date

Were there any changes to the standard payment terms in the reporting period?

No information available

Any other information about payment terms

No additional information

Maximum contractual payment period agreed

60

Dispute Resolution Process

Takeda Business Solutions (TBS), is responsible for maintaining supplier information, PO processing, invoice processing and payments. Please note the following important points about contacting us.We operate a ticketing system to ensure all queries are recorded and responded to within agreed timelines.All new queries will be assigned a Case Number and [ref: XXX]These numbers should be quoted on all replies to TBS. You’ll find it in the subject line of our auto-reply. Please use this case number if following up on your email or reply directly to our case email. Query handing email address : accountspayableEU@shire.com

Other Payment Information

Has this business signed up to a code of conduct or standards on payment practices?

For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.

Does this business offer e-invoicing in relation to qualifying contracts?

This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.

Does this business offer supply chain finance?

This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.

Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?

During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?

No information available

Company Summary

SHIRE PHARMACEUTICALS LIMITED is a global biopharmaceutical company that focuses on developing and providing innovative treatments for rare diseases and other specialty conditions. The company was founded in 1986 and its registered office address is located in Dublin, Ireland.

The company's sustainability program is an integral part of their business strategy and operations. They aim to reduce their environmental impact, promote ethical and responsible practices, and contribute to the health and well-being of the communities they serve. This includes initiatives such as reducing greenhouse gas emissions, promoting diversity and inclusion, and supporting local communities through philanthropic efforts.

SHIRE PHARMACEUTICALS LIMITED offers a wide range of products and services in the areas of rare diseases, neuroscience, gastrointestinal, and internal medicine. Their portfolio includes treatments for conditions such as hemophilia, Hunter syndrome, and ADHD. They also provide support and resources for patients and their families through their patient advocacy program.

The key people at SHIRE PHARMACEUTICALS LIMITED include their CEO, Flemming Ornskov, and a team of experienced executives and scientists. Together, they are committed to driving the company's mission of improving the lives of patients with rare diseases and other specialty conditions.

To learn more about SHIRE PHARMACEUTICALS LIMITED and their products and services, you can visit their website at www.shire.com. The website also provides contact information for their global headquarters and regional offices.

Financial Metrics

Cash
£0
Net Worth
£7,852,000
Total Current Assets
£10,152,000
Total Current Liabilities
£2,300,000

Company Location